LIMK1 and colonic neoplasm: Transwell results showed that, compared with the control group (shRNA-NC), the number of colon cancer cells crossing the basement membrane was significantly reduced in the shRNA-LIMK1 group, with a statistically significant difference (Figure 3(b)).